These findings collectively establish that PPARγ activation orchestrates a protective anti-fibrotic and anti-inflammatory network via miRNA and lncRNA regulation, making it a promising therapeutic target in myocardial fibrosis. This evidence concerns the gene PPARG and Myocardial fibrosis.